TY - JOUR
T1 - Psychedelic Identity Shift
T2 - A Critical Approach to Set And Setting
AU - Devenot, Neşe
AU - Seale-Feldman, Aidan
AU - Smith, Elyse
AU - Noorani, Tehseen
AU - Garcia-Romeu, Albert
AU - Johnson, Matthew W.
N1 - Funding Information:
Matthew W. Johnson Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Funding: The smoking cessation study upon which this qualitative study is based was funded by Heffter Research Institute, the Beckley Foundation, and William Harrison. Support for manuscript preparation for AGR and MWJ was provided by Tim Ferriss, Matt Mullenweg, Craig Nerenberg, Blake Mycoskie, and the Steven and Alexandra Cohen Foundation.
Funding Information:
The smoking cessation study upon which this qualitative study is based was funded by Heffter Research Institute, the Beckley Foundation, and William Harrison. Support for manuscript preparation for AGR and MWJ was provided by Tim Ferriss, Matt Mullenweg, Craig Nerenberg, Blake Mycoskie, and the Steven and Alexandra Cohen Foundation.ND is an unpaid board member of Psymposia, a 501c3 nonprofit research organization. TN is a part-time scholar-in-residence at Tactogen Public Benefit Corporation. AGR is a paid scientific advisor to ETHA Natural Botanicals and NeonMind Biosciences. MWJ has been in paid advisory relationships with the following organizations regarding the medical development of psychedelics and related compounds: AJNA Labs LLC, AWAKN Life Sciences Inc., Beckley Psychedelic Ltd., Entheon Biomedical Corp., Field Trip Psychedelics Inc., Mind Medicine Inc., Silo Pharma, Inc., and Otsuka Pharmaceutical Development & Commercialization Inc.
Publisher Copyright:
© 2023 by Johns Hopkins University Press.
PY - 2022/12
Y1 - 2022/12
N2 - While the literature on psychedelic medicine emphasizes the importance of set and setting alongside the quality of subjective drug effects for therapeutic efficacy, few scholars have explored the therapeutic frameworks that are used alongside psychedelics in the lab or in the clinic. Based on a narrative analysis of the treatment manual and post-session experience reports from a pilot study of psilocybin-assisted treatment for tobacco smoking cessation, this article examines how therapeutic frameworks interact with the psychedelic substance in ways that can rapidly reshape participants’ identity and sense of self. We identified multiple domains relating to identity shift that appear to serve as smoking cessation mechanisms during psilocybin sessions, each of which had an identifiable presence in the manualized treatment. As psychedelic medicine becomes mainstream, consensual and evidence-based approaches to psychedelic-assisted identity shift that respect patient autonomy and encourage empowerment should become areas of focus in the emergent field of psychedelic bioethics.
AB - While the literature on psychedelic medicine emphasizes the importance of set and setting alongside the quality of subjective drug effects for therapeutic efficacy, few scholars have explored the therapeutic frameworks that are used alongside psychedelics in the lab or in the clinic. Based on a narrative analysis of the treatment manual and post-session experience reports from a pilot study of psilocybin-assisted treatment for tobacco smoking cessation, this article examines how therapeutic frameworks interact with the psychedelic substance in ways that can rapidly reshape participants’ identity and sense of self. We identified multiple domains relating to identity shift that appear to serve as smoking cessation mechanisms during psilocybin sessions, each of which had an identifiable presence in the manualized treatment. As psychedelic medicine becomes mainstream, consensual and evidence-based approaches to psychedelic-assisted identity shift that respect patient autonomy and encourage empowerment should become areas of focus in the emergent field of psychedelic bioethics.
UR - http://www.scopus.com/inward/record.url?scp=85147970530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147970530&partnerID=8YFLogxK
U2 - 10.1353/ken.2022.0022
DO - 10.1353/ken.2022.0022
M3 - Article
AN - SCOPUS:85147970530
SN - 1054-6863
VL - 32
SP - 359
EP - 399
JO - Kennedy Institute of Ethics Journal
JF - Kennedy Institute of Ethics Journal
IS - 4
ER -